Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: Better drug or reduced vancomycin susceptibility? [5] (multiple letters)

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4816-4817

  Howden, Benjamin P ^a   Charles, Patrick G P ^a   Johnson, Paul D R ^a   Ward, Peter B ^a   Grayson, M Lindsay ^a   Weigelt, John A ^b   Itani, Kamal ^c   Stevens, Dennis ^d   Lau, William ^e   Dryden, Matthew ^f   Knirsch, Charles ^g  

^a AUSTIN HEALTH   (Australia)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Boise VA Medical Center   (United States)

^e St Francis Healthcare System of Hawaii   (United States)

^f ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^g Pfizer World Wide Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; METICILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; AUSTRALIA; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HOSPITAL INFECTION; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ACETAMIDES; HUMANS; METHICILLIN RESISTANCE; OXAZOLIDINONES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 27644599008     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4816-4817.2005     Document Type: Letter

References (0)